TrialBreast cancer research and treatment2024

A randomized phase II study of metronomic cyclophosphamide and methotrexate (CM) with or without bevacizumab in patients with advanced breast cancer.

Erica L Mayer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.